LYEL EPS Estimates
Lyell Immunopharma, Inc.
$9.38
-$0.03(-0.32%)
43
Overall
60
Value
27
Tech
42
Quality
Market Cap
$229.86M
Volume
93.16K
52W Range
$7.20 - $45.00
Target Price
$36.67
LYEL EPS estimates: the consensus estimate for Lyell Immunopharma, Inc.'s current fiscal year is -$7.16 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
LYEL EPS Estimates
- EPS estimate, current quarter
- $-2.06
- EPS estimate, next quarter
- $-1.98
- EPS estimate, current year
- $-7.16
- EPS estimate, next year
- $-7.21
- EPS growth, 3-year
- -2.76%
| Fiscal year | EPS |
|---|---|
| 2025 | $-16.06 |
| 2024 | $-26.20 |
| 2023 | $-18.60 |
| 2022 | $-14.80 |
| 2021 | $-36.80 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LYEL | $9.38 | -0.3% | 93.16K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Lyell Immunopharma, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW